France’s Beaune: Higher vaccine prices due to Delta variant adaptation

PARIS — The price increase for Pfizer and Moderna’s COVID-19 vaccines is caused by the jabs’ adaptation to the Delta variant, France’s Junior Minister for European Affairs Clément Beaune said today. “To have more demanding contracts with products adapted to the variants will — probably, yes — be a little more expensive, not only for the EU, but […]

France’s Beaune: Higher vaccine prices due to Delta variant adaptation

PARIS — The price increase for Pfizer and Moderna’s COVID-19 vaccines is caused by the jabs’ adaptation to the Delta variant, France’s Junior Minister for European Affairs Clément Beaune said today.

“To have more demanding contracts with products adapted to the variants will — probably, yes — be a little more expensive, not only for the EU, but for all buyers,” the French politician told radio station Radio France internationale.

Sunday evening, the Financial Times reported that Pfizer and Moderna had ramped up their prices — a Pfizer jab now costs €19.50 instead of €15.50, and a Moderna jab is now €21.50 instead of €19. The EU’s executive body declined to comment to the Agence France-Presse, but Beaune’s statements effectively corroborate the Financial Times’ report.

“The vaccine doses that the EU is currently negotiating with Pfizer and other laboratories are not the same as the first generation of vaccines. They’re being adapted, as is requested by the contracts under negotiation, to the variants,” Beaune said. He added that the EU also requested that the majority of production — “almost 300,000 vaccine components” — be produced in Europe.

The delivery schedules will be “more precise,” the French junior minister explained, with financial penalties if they’re not respected by the labs.

Beaune said that the contracts will become public once they’re finalized.